Micro Imaging Technology Names Vice President Business Development

SAN CLEMENTE, CA--(Marketwire - August 7, 2007) - Micro Imaging Technology, Inc. (OTCBB: MMTC) announced that John Ricardi has been appointed Vice President Business Development.

Mr. Ricardi brings 30 years of experience in commercializing and developing sales for high-technology products and systems to his new position with MIT. He most recently served as Vice President Sensor Products at JMAR Technologies where he led the development and commercialization of the company's real-time water monitoring system since its conception and was responsible for all aspects of the Sensor business segment. From 1997 through 1999, Mr. Ricardi served as Vice President of Corporate Development for JMAR Technologies Inc. and as Senior Vice President of Sales and Marketing of JMAR's Precision Systems operation in Chatsworth, California. Prior to JMAR, he held senior sales and marketing positions with the Imaging Systems Division of Datron Advanced Technologies, a California-based manufacturer of advanced telecommunications products.

"John's knowledge of the water industry, coupled with his engineering background and business development experience, makes him a perfect fit to plan and execute the commercialization of our unique rapid pathogenic detection system," stated Michael Brennan, MIT's Chairman and CEO. "We are very pleased to have John on our team."

Micro Imaging Technology (MIT)

The Company's subsidiary, MIT, has developed and patented a laser-based technology for rapid microbe detection and identification. The system measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. The MIT System is non-biological and does not rely on biological agents, conventional chemical processing, fluorescent tags, gas chromatography or DNA analysis.

MIT has demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, Shigella and other pathogenic bacteria. The identification process has been verified by North American Science Associates, Inc. (NAMSA), an independent, internationally recognized biological testing laboratory. The Test Report, in the Company's opinion, demonstrated the accuracy, speed and efficiency of the MIT system over conventional processes and is available from the Company.

This release contains statements that are forward looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

Contact Information: FOR FURTHER INFORMATION, CONTACT: Michael Brennan Chairman Micro Imaging Technology, Inc. Email: Telephone: (805) 557-0614